BioDlink International Company Limited

SEHK:1875 Stock Report

Market Cap: HK$1.5b

BioDlink International Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure3.8yrs
Board average tenureless than a year

Recent management updates

TOT BIOPHARM International Company Limited's (HKG:1875) CEO Will Probably Find It Hard To See A Huge Raise This Year

Jun 13
TOT BIOPHARM International Company Limited's (HKG:1875) CEO Will Probably Find It Hard To See A Huge Raise This Year

Recent updates

Benign Growth For TOT BIOPHARM International Company Limited (HKG:1875) Underpins Its Share Price

Jul 24
Benign Growth For TOT BIOPHARM International Company Limited (HKG:1875) Underpins Its Share Price

TOT BIOPHARM International Company Limited's (HKG:1875) CEO Will Probably Find It Hard To See A Huge Raise This Year

Jun 13
TOT BIOPHARM International Company Limited's (HKG:1875) CEO Will Probably Find It Hard To See A Huge Raise This Year

Is TOT BIOPHARM International (HKG:1875) A Risky Investment?

Apr 10
Is TOT BIOPHARM International (HKG:1875) A Risky Investment?

TOT BIOPHARM International Company Limited's (HKG:1875) Low P/S No Reason For Excitement

Dec 18
TOT BIOPHARM International Company Limited's (HKG:1875) Low P/S No Reason For Excitement

We Think Some Shareholders May Hesitate To Increase TOT BIOPHARM International Company Limited's (HKG:1875) CEO Compensation

Jun 07
We Think Some Shareholders May Hesitate To Increase TOT BIOPHARM International Company Limited's (HKG:1875) CEO Compensation

The Market Lifts TOT BIOPHARM International Company Limited (HKG:1875) Shares 29% But It Can Do More

May 21
The Market Lifts TOT BIOPHARM International Company Limited (HKG:1875) Shares 29% But It Can Do More

Is TOT BIOPHARM International (HKG:1875) Using Debt In A Risky Way?

Mar 18
Is TOT BIOPHARM International (HKG:1875) Using Debt In A Risky Way?

There's No Escaping TOT BIOPHARM International Company Limited's (HKG:1875) Muted Revenues

Dec 28
There's No Escaping TOT BIOPHARM International Company Limited's (HKG:1875) Muted Revenues

Does TOT BIOPHARM International (HKG:1875) Have A Healthy Balance Sheet?

Nov 23
Does TOT BIOPHARM International (HKG:1875) Have A Healthy Balance Sheet?

We Think TOT BIOPHARM International (HKG:1875) Has A Fair Chunk Of Debt

May 18
We Think TOT BIOPHARM International (HKG:1875) Has A Fair Chunk Of Debt

Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

Jul 27
Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

An Intrinsic Calculation For TOT BIOPHARM International Company Limited (HKG:1875) Suggests It's 41% Undervalued

Mar 26
An Intrinsic Calculation For TOT BIOPHARM International Company Limited (HKG:1875) Suggests It's 41% Undervalued

Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

Feb 03
Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

CEO

BioDlink International has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Shan Fu
Executive Chairperson of the Board9.8yrsno datano data
Ben Xiao
Group Vice President of Finance & Investor Relations3.8yrsno datano data
Wing Yat Lui
Joint Company Secretary6.6yrsno datano data
Yifan Chen
Joint Company Secretary3.8yrsno datano data
3.8yrs
Average Tenure
44yo
Average Age

Experienced Management: 1875's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Shan Fu
Executive Chairperson of the Board9.8yrsno datano data
Weidong Liu
Non-Executive Director2.3yrsno datano data
Xuelin Gu
Independent Non-Executive Directorless than a yearno datano data
Hui Sun
Independent Non-Executive Directorless than a yearno datano data
Qing Zhang
Independent Non-Executive Directorless than a yearno datano data
0.7yrs
Average Tenure
56yo
Average Age

Experienced Board: 1875's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/06 07:03
End of Day Share Price 2025/11/06 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioDlink International Company Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xin Qiu LinGuoyuan Securities (HK) Ltd
Yue-Kwong LuiJefferies LLC